Works matching AU Knop, Stefan

Results: 68
    1

    Kardiale Amyloidose.

    Published in:
    Medizinische Klinik (Urban & Vogel), 2008, v. 103, n. 3, p. 153
    By:
    • Christiane Angermann;
    • Stefan Knop;
    • Georg Ertl;
    • Stefan Störk
    Publication type:
    Article
    2
    3
    4
    5

    Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 1, p. 205, doi. 10.1007/s00432-020-03323-6
    By:
    • Hose, Dorothea;
    • Schreder, Martin;
    • Hefner, Jochen;
    • Bittrich, Max;
    • Danhof, Sophia;
    • Strifler, Susanne;
    • Krauth, Maria-Theresa;
    • Schoder, Renate;
    • Gisslinger, Bettina;
    • Einsele, Hermann;
    • Gisslinger, Heinz;
    • Knop, Stefan
    Publication type:
    Article
    6

    Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN).

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 3, p. 749, doi. 10.1007/s00432-019-03101-z
    By:
    • Brioli, Annamaria;
    • Manz, Kirsi;
    • Pfirrmann, Markus;
    • Hänel, Mathias;
    • Schwarzer, Andreas Christoph;
    • Prange-Krex, Gabriele;
    • Fabisch, Christian;
    • Knop, Stefan;
    • Illmer, Thomas;
    • Krammer-Steiner, Beate;
    • Hochhaus, Andreas;
    • von Lilienfeld-Toal, Marie;
    • Mügge, Lars-Olof
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma?: Exploring a large single center database using artificial intelligence.

    Published in:
    Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5215, doi. 10.1007/s10238-023-01100-6
    By:
    • Bittrich, Max;
    • Hetterich, Regina;
    • Solimando, Antonio G.;
    • Krebs, Markus;
    • Loda, Sophia;
    • Danhof, Sophia;
    • Anton, Straub;
    • Zhou, Xiang;
    • Kerscher, Alexander;
    • Beilhack, Andreas;
    • Kortüm, K. Martin;
    • Rasche, Leo;
    • Einsele, Hermann;
    • Knop, Stefan;
    • Hartmann, Stefan
    Publication type:
    Article
    16

    A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma

    Published in:
    EJHaem, 2024, v. 5, n. 5, p. 940, doi. 10.1002/jha2.968
    By:
    • Knop, Stefan;
    • Szarejko, Monika;
    • Grząśko, Norbert;
    • Bringhen, Sara;
    • Trautmann‐Grill, Karolin;
    • Jurczyszyn, Artur;
    • Vacca, Angelo;
    • Khandanpour, Cyrus;
    • Gamberi, Barbara;
    • Pour, Ludek;
    • Iversen, Katrine F.;
    • Stumpp, Michael T.;
    • Suter, Cosima;
    • Dawson, Keith M.;
    • Zitt, Christof;
    • Legenne, Philippe;
    • Stavropoulou, Vaia;
    • Fey, Martin F.;
    • Leupin, Nicolas;
    • Goldschmidt, Hartmut
    Publication type:
    Article
    17

    Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based therapy (AGMT MM 1, phase II trial).

    Published in:
    EJHaem, 2021, v. 2, n. 1, p. 102, doi. 10.1002/jha2.130
    By:
    • Ludwig, Heinz;
    • Hausmann, Bela;
    • Schreder, Martin;
    • Pönisch, Wolfram;
    • Zojer, Niklas;
    • Knop, Stefan;
    • Gunsilius, Eberhard;
    • Egle, Alexander;
    • Petzer, Andreas;
    • Einsele, Hermann;
    • Hajek, Roman;
    • Weisel, Katja;
    • Krenosz, Karl Jochen;
    • Lang, Alois;
    • Lechner, Daniel;
    • Greil, Richard;
    • Berry, David
    Publication type:
    Article
    18

    Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 785, doi. 10.1016/j.clml.2021.06.005
    By:
    • Mateos, Maria-Victoria;
    • Dimopoulos, Meletios A.;
    • Cavo, Michele;
    • Suzuki, Kenshi;
    • Knop, Stefan;
    • Doyen, Chantal;
    • Lucio, Paulo;
    • Nagy, Zsolt;
    • Pour, Ludek;
    • Grosicki, Sebastian;
    • Crepaldi, Andre;
    • Liberati, Anna Marina;
    • Campbell, Philip;
    • Yoon, Sung-Soo;
    • Iosava, Genadi;
    • Fujisaki, Tomoaki;
    • Garg, Mamta;
    • Iida, Shinsuke;
    • Bladé, Joan;
    • Ukropec, Jon
    Publication type:
    Article
    19

    P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S150, doi. 10.1016/S2152-2650(21)02330-2
    By:
    • Lonial, Sagar;
    • Berdeja, Jesus G.;
    • Dimopoulos, Meletios-Athanasios;
    • Jagannath, Sundar;
    • Knop, Stefan;
    • Hang Quach;
    • Rodríguez-Otero, Paula;
    • Richardson, Paul G.;
    • Sorrell, April;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • Tuong Vi Nguyen;
    • Hong, Kevin;
    • Peluso, Teresa;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    20

    OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5
    By:
    • Lonial, Sagar;
    • Richardson, Paul G.;
    • Popat, Rakesh;
    • Stadtmauer, Edward A.;
    • Larsen, Jeremy T.;
    • Oriol, A.;
    • Knop, Stefan;
    • Jagannath, Sundar;
    • Cook, Gordon;
    • Badros, Ashraf Z.;
    • Rodríguez-Otero, Paula;
    • Siegel, David S.;
    • Tuong Vi Nguyen;
    • Micco, Antonia Di;
    • Amin, Alpesh;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    21
    22
    23
    24
    25

    The Diagnosis and Treatment of Multiple Myeloma.

    Published in:
    Deutsches Ärzteblatt International, 2016, v. 113, n. 27/28, p. 470, doi. 10.3238/arztebl.2016.0470
    By:
    • Gerecke, Christian;
    • Fuhrmann, Stephan;
    • Strifler, Susanne;
    • Schmidt-Hieber, Martin;
    • Einsele, Hermann;
    • Knop, Stefan
    Publication type:
    Article
    26

    First-in-Human Experience of CXCR4-Directed Endoradiotherapy with <sup>177</sup>Lu- and <sup>90</sup>Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.

    Published in:
    Journal of Nuclear Medicine, 2016, v. 57, n. 2, p. 248, doi. 10.2967/jnumed.115.167361
    By:
    • Herrmann, Ken;
    • Schottelius, Margret;
    • Lapa, Constantin;
    • Osl, Theresa;
    • Poschenrieder, Andreas;
    • Hänscheid, Heribert;
    • Lückerath, Katharina;
    • Schreder, Martin;
    • Bluemel, Christina;
    • Knott, Markus;
    • Keller, Ulrich;
    • Schirbel, Andreas;
    • Samnick, Samuel;
    • Lassmann, Michael;
    • Kropf, Saskia;
    • Buck, Andreas K.;
    • Einsele, Hermann;
    • Wester, Hans-Juergen;
    • Knop, Stefan
    Publication type:
    Article
    27
    28

    AA amyloidosis in inflammatory active malignant paraganglioma.

    Published in:
    Amyloid, 2022, v. 29, n. 2, p. 137, doi. 10.1080/13506129.2021.2016691
    By:
    • Ihne, Sandra;
    • Kircher, Malte;
    • Papagianni, Aikaterini;
    • Goetze, Oliver;
    • Morbach, Caroline;
    • Werner, Rudolf A.;
    • Zeller, Daniel;
    • Sommer, Claudia;
    • Rosenwald, Andreas;
    • Amann, Kerstin;
    • Linke, Reinhold P.;
    • Lapa, Constantin;
    • Einsele, Hermann;
    • Geier, Andreas;
    • Obici, Laura;
    • Palladini, Giovanni;
    • Knop, Stefan;
    • Störk, Stefan
    Publication type:
    Article
    29
    30
    31

    Prognostic value of [<sup>18</sup>F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 10, p. 1694, doi. 10.1007/s00259-018-3997-0
    By:
    • Stolzenburg, Antje;
    • Lückerath, Katharina;
    • Samnick, Samuel;
    • Speer, Martin;
    • Kneer, Katharina;
    • Schmid, Jan-Stefan;
    • Grigoleit, Götz Ulrich;
    • Hofmann, Susanne;
    • Beer, Ambros J.;
    • Bunjes, Donald;
    • Knop, Stefan;
    • Buck, Andreas K.;
    • Einsele, Hermann;
    • Lapa, Constantin
    Publication type:
    Article
    32
    33

    Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)

    Published in:
    Frontiers in Hematology, 2024, p. 1, doi. 10.3389/frhem.2024.1436845
    By:
    • Leitner, Theo;
    • Shumilov, Evgenii;
    • Schwitlick, Christina;
    • Koch, Raphael;
    • Hamm, Franziska;
    • Högner, Marion;
    • Bassermann, Florian;
    • Weisel, Katja;
    • Einsele, Hermann;
    • Kortüm, Martin;
    • Rasche, Leo;
    • Görner, Martin;
    • Wegehenkel, Kai;
    • Knop, Stefan;
    • Krönke, Jan;
    • Nogai, Axel;
    • König, Inke R.;
    • Vens, Maren;
    • Horn, Kay;
    • von Bubnoff, Nikolas
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42

    In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.

    Published in:
    EMBO Molecular Medicine, 2015, v. 7, n. 4, p. 477, doi. 10.15252/emmm.201404698
    By:
    • Philipp‐Abbrederis, Kathrin;
    • Herrmann, Ken;
    • Knop, Stefan;
    • Schottelius, Margret;
    • Eiber, Matthias;
    • Lückerath, Katharina;
    • Pietschmann, Elke;
    • Habringer, Stefan;
    • Gerngroß, Carlos;
    • Franke, Katharina;
    • Rudelius, Martina;
    • Schirbel, Andreas;
    • Lapa, Constantin;
    • Schwamborn, Kristina;
    • Steidle, Sabine;
    • Hartmann, Elena;
    • Rosenwald, Andreas;
    • Kropf, Saskia;
    • Beer, Ambros J;
    • Peschel, Christian
    Publication type:
    Article
    43
    44
    45
    46

    Targeted sequencing using a 47 gene multiple myeloma mutation panel (M<sup>3</sup>P) in -17p high risk disease.

    Published in:
    British Journal of Haematology, 2015, v. 168, n. 4, p. 507, doi. 10.1111/bjh.13171
    By:
    • Kortüm, Klaus M.;
    • Langer, Christian;
    • Monge, Jorge;
    • Bruins, Laura;
    • Egan, Jan B.;
    • Zhu, Yuan X.;
    • Shi, Chang Xin;
    • Jedlowski, Patrick;
    • Schmidt, Jessica;
    • Ojha, Juhi;
    • Bullinger, Lars;
    • Liebisch, Peter;
    • Kull, Miriam;
    • Champion, Mia D.;
    • Van Wier, Scott;
    • Ahmann, Gregory;
    • Rasche, Leo;
    • Knop, Stefan;
    • Fonseca, Rafael;
    • Einsele, Hermann
    Publication type:
    Article
    47

    Cardio-Hepatic Interaction in Cardiac Amyloidosis.

    Published in:
    Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1440, doi. 10.3390/jcm13051440
    By:
    • Ihne-Schubert, Sandra Michaela;
    • Goetze, Oliver;
    • Gerstendörfer, Felix;
    • Sahiti, Floran;
    • Schade, Ina;
    • Papagianni, Aikaterini;
    • Morbach, Caroline;
    • Frantz, Stefan;
    • Einsele, Hermann;
    • Knop, Stefan;
    • Sommer, Claudia;
    • Müllhaupt, Beat;
    • Schubert, Torben;
    • Störk, Stefan;
    • Geier, Andreas
    Publication type:
    Article
    48
    49

    Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.

    Published in:
    European Journal of Haematology, 2021, v. 107, n. 5, p. 529, doi. 10.1111/ejh.13690
    By:
    • Straka, Christian;
    • Salwender, Hans;
    • Knop, Stefan;
    • Vogel, Martin;
    • Müller, Jürgen;
    • Metzner, Bernd;
    • Langer, Christian;
    • Sayer, Herbert;
    • Jung, Wolfram;
    • Dürk, Heinz A.;
    • Bassermann, Florian;
    • Gramatzki, Martin;
    • Rösler, Wolf;
    • Wolf, Hans‐Heinrich;
    • Brugger, Wolfram;
    • Engelhardt, Monika;
    • Fischer, Thomas;
    • Liebisch, Peter;
    • Einsele, Hermann
    Publication type:
    Article
    50

    Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials.

    Published in:
    European Journal of Haematology, 2019, v. 103, n. 3, p. 255, doi. 10.1111/ejh.13281
    By:
    • Straka, Christian;
    • Knop, Stefan;
    • Vogel, Martin;
    • Müller, Jürgen;
    • Kropff, Martin;
    • Metzner, Bernd;
    • Langer, Christian;
    • Sayer, Herbert;
    • Jung, Wolfram;
    • Dürk, Heinz A.;
    • Salwender, Hans;
    • Wandt, Hannes;
    • Bassermann, Florian;
    • Gramatzki, Martin;
    • Rösler, Wolf;
    • Wolf, Hans‐Heinrich;
    • Brugger, Wolfram;
    • Fischer, Thomas;
    • Liebisch, Peter;
    • Engelhardt, Monika
    Publication type:
    Article